Live From Global Forum Chicago:

When in Iceland…consider these potential "cold chain" pitfalls. Even if you don’t ship temperature-sensitive medications in this country, here are three case studies whose challenges bear consideration.

When in Iceland…Consider These Potential “Cold Chain” Pitfalls. Even if you don’t ship temperature-sensitive medications in this country, here are three case studies whose challenges bear consideration.
When in Iceland…Consider These Potential “Cold Chain” Pitfalls. Even if you don’t ship temperature-sensitive medications in this country, here are three case studies whose challenges bear consideration.

Iceland is about the size of Kentucky, but with only 8% of that state’s population. All total, Iceland’s population numbers 340,000. With 60 primary care facilities, 250,000 patients, and 98 pharmacies, there can’t be many challenges to shipping temperature-sensitive medications, right? Just make certain the shipment can withstand extreme cold weather and it’s good to go, right?

Not so fast. As Vallý Helgadóttir illustrated via three case studies presented Sept. 27 during the Global Forum 15th Annual Temperature Controlled Life Science Supply Chain event in Chicago, plenty of things can derail even well-planned, systematic healthcare logistics efforts.

Helgadóttir is the Director of Customer Service for Distica, a specialized company in logistics, warehousing and distribution of pharmaceuticals, healthcare and medical products for the healthcare sector and laboratories in Iceland.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?